Free Trial
NYSE:ARDT

Ardent Health (ARDT) Stock Price, News & Analysis

Ardent Health logo
$9.39 +0.56 (+6.33%)
Closing price 06/9/2026 03:59 PM Eastern
Extended Trading
$9.40 +0.01 (+0.12%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Ardent Health Stock (NYSE:ARDT)

Advanced

Key Stats

Today's Range
$8.76
$9.43
50-Day Range
$7.87
$10.26
52-Week Range
$7.71
$15.48
Volume
556,297 shs
Average Volume
531,545 shs
Market Capitalization
$1.35 billion
P/E Ratio
9.88
Dividend Yield
N/A
Price Target
$14.21
Consensus Rating
Hold

Company Overview

Ardent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

ARDT MarketRank™: 

Ardent Health scored higher than 87% of companies evaluated by MarketBeat, and ranked 39th out of 857 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ardent Health has received a consensus rating of Hold. The company's average rating score is 2.36, and is based on no strong buy ratings, 7 buy ratings, 5 hold ratings, and 2 sell ratings.

  • Upside Potential

    Ardent Health has a consensus price target of $14.21, representing about 51.3% upside from its current price of $9.39.

  • Amount of Analyst Coverage

    Ardent Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Ardent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Ardent Health are expected to grow by 10.71% in the coming year, from $1.12 to $1.24 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ardent Health is 9.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.52.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ardent Health is 9.88, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.74.

  • Price to Earnings Growth Ratio

    Ardent Health has a PEG Ratio of 1.97. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Ardent Health has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ardent Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.15% of the float of Ardent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardent Health has a short interest ratio ("days to cover") of 7.37.
  • Change versus previous month

    Short interest in Ardent Health has recently increased by 5.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Ardent Health does not currently pay a dividend.

  • Dividend Growth

    Ardent Health does not have a long track record of dividend growth.

  • News Sentiment

    Ardent Health has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Ardent Health this week, compared to 9 articles on an average week.
  • Search Interest

    Only 2 people have searched for ARDT on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Ardent Health to their MarketBeat watchlist in the last 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $88,100.00 in company stock, which represents 0.0065% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Ardent Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $88,100.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    1.90% of the stock of Ardent Health is held by insiders.

  • Percentage Held by Institutions

    Ardent Health has minimal institutional ownership at this time.

  • Read more about Ardent Health's insider trading history.
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARDT Stock News Headlines

He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategist at The Oxford Club, AI is doubling in power every 6 months - and the implications for investors are staggering. Green warns that holding the leading AI stocks could be the wrong move as this shift accelerates. With 41 years of market experience, he says a rare window is open right now - but not for long.tc pixel
Ardent Health Appoints Dave Caspers as CEO
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health's stock was trading at $8.81 at the start of the year. Since then, ARDT shares have increased by 6.6% and is now trading at $9.3890.

Ardent Health, Inc. (NYSE:ARDT) announced its quarterly earnings data on Tuesday, May, 5th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.10. The company earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a trailing twelve-month return on equity of 13.85% and a net margin of 2.09%.
Read the conference call transcript
.

Ardent Health (ARDT) raised $252 million in an initial public offering on Thursday, July 18th 2024. The company issued 12,000,000 shares at $20.00-$22.00 per share.

Ardent Health's top institutional shareholders include Empowered Funds LLC (0.37%), First Trust Advisors LP (0.33%), Bank of America Corp DE (0.25%) and Bank of New York Mellon Corp (0.17%).
View institutional ownership trends
.

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
5/05/2026
Today
6/09/2026
Goldman Sachs 47th Annual Global Healthcare Conference 2026
6/10/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
CIK
1756655
Web
N/A
Fax
N/A
Employees
25,200
Year Founded
2001

Price Target and Rating

High Price Target
$20.00
Low Price Target
$10.00
Potential Upside/Downside
+51.3%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.95
Trailing P/E Ratio
9.88
Forward P/E Ratio
8.38
P/E Growth
1.97
Net Income
$135.81 million
Net Margins
2.09%
Pretax Margin
4.46%
Return on Equity
13.85%
Return on Assets
4.48%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
2.12
Quick Ratio
2.00

Sales & Book Value

Annual Sales
$6.32 billion
Price / Sales
0.21
Cash Flow
$2.92 per share
Price / Cash Flow
3.21
Book Value
$11.78 per share
Price / Book
0.80

Miscellaneous

Outstanding Shares
143,350,000
Free Float
140,626,000
Market Cap
$1.35 billion
Optionable
Optionable
Beta
0.84

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSE:ARDT) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners